Vaccine Sales Market Forecast 2018-2028

“The Russian Vaccines Revenue Forecast”
This brand new report covers Paediatric Vaccines, Adult Vaccines, Elderly Vaccines, Travel Vaccines, Therapeutic Vaccines, Prevnar, Gardasil, Fluzone, Pentacel, ProQuad, Infanrix/Pediarix, Zostavax, RotaTeq and Menactra.

The Global Vaccines Sales market was valued at $36.9 billion in 2017. This value will grow to $61.1bn in 2022 and it is expected to reach $114.2bn in 2028. The CAGR for the Global Vaccines Sales market from 2018-2028 is expected to be 10.9%.

Vaccines – Your 2018 Guide to Developments, Opportunities and Revenues
What does the future hold for vaccine sales? Visiongain’s updated report shows you forecasted sales at overall world market, submarket, product and national level to 2028.

With that study you discover vaccine trends, R&D and revenue prospects for human healthcare. That way you can benefit your research, analysis, decisions and authority. For those technologies, assess sales potentials and opportunities.

Vaccines still hold great technological, medical and commercial potential. See why and what is possible. Read on, then, to explore that industry and see a revenue prediction.


Would you like to read the report overview? If so pelase email me today on or call me on +44 207 549 9987


Forecasts from 2018 to 2028 and other analyses showing you vaccine market potentials
Besides revenue forecasting to 2028, our new study gives you historical data, recent results, growth rates and market shares. There you find business outlooks and developments (R&D).

Our report gives you 53 tables and 56 charts. Gain analysis found nowhere else. Discover what the future holds for companies and the vaccines market.

Gains through exploring the vaccines industry – ways to benefit your plans and decisions
Leaders hold the latest knowledge – research and analysis. So explore, in our report, the development, production and sales of vaccines. There, from 2018, you see where needs and money exist for those preventative medicines. Discover what is possible.

Our study’s purpose is to help you avoid struggles to gain business data on vaccines. See how our predictions and discussions could benefit your reputation for commercial insight.

Discover, then, how you and your organisation can gain. The following sections show how our new investigation benefits your plans, decisions and presentations.

Would you like to read the report overview? If so pelase email me today on or call me on +44 207 549 9987


Revenues for the world vaccines market and submarkets – what is possible?
What is that industry’s potential? What are the secrets of its progress? Discover in our report overall world revenue forecasting to 2028. Also find individual predictions for four world level submarkets:
• Paediatric vaccines
• Adult vaccines
• Elderly vaccines
• Travel vaccines
• Therapeutic Vaccines


Sample pages can be found at:


Forecasts and discussions for leading marketed products
How will leading brands perform from 2018 at world level? Our work shows you 10 individual revenue forecasts to 2028 for leading vaccines:
• Prevnar
• Gardasil
• Fluzone
• Pentacel
• ProQuad/M-M-R- II/Varivax.
• Infanrix/Pediarix
• Zostavax
• RotaTeq
• GSK hepatitis Vaccines
• Menactra.

Companies listed in this report include: 


Bavarian Nordic



Cancer Research UK

Centre for Biologics Evaluation and Research (CBER)

Centre for Disease Control and Prevention (CDC)

Food and Drugs Administration (FDA)

GlaxoSmithKline (GSK)

Global Alliance for Vaccines and Immunization (GAVI)


InterveXion Therapeutics

Johnson and Johnson

LigoCyte Pharmaceuticals

Merck & Co.






Servizio Sanitario Nazionale (SSN)


Themis Bioscience

US National Cancer Institute

World Health Organisation (WHO)


Report sample pages can be found at:



Media Contact
Company Name: Visiongain Limited
Contact Person: Sara Peerun
Email: Send Email
Phone: +44 207 3366100
Address:143 Airport House, Purley way
City: London CR0 0XZ
Country: United Kingdom